GLG News by Managed Care Pricing Trends Experts

William FinkPresidentManaged Care Pharmacy Consultants, Inc

"Health Care Laws by Any Name Will Not Work"

June 15, 2011

You can name the health care laws "ObamaCare", "Palin Care", "Trump Care", "Huckabee Care", or any "Care" you want, but they will not work, because it is not the laws that are messed up it is the public that is messed up.

William FinkPresidentManaged Care Pharmacy Consultants, Inc

PBMs NOT ALWAYS THE BAD GUYS

May 11, 2011

There are many articles written by attorneys explaining how they can write contracts with the PBMs in order to save their clients a great deal of money.

William FinkPresidentManaged Care Pharmacy Consultants, Inc

Does the Teva Cephalon Deal have an unknown problem?

May 3, 2011

Analysis of:Teva to acquire Cephalon in 6.8 Billion Transaction | www.glgroup.com

Teva is embarking on a new and exciting future for its "Branded Business" Teva wants to obtain the "Dollars" from PROVIGIL. Provigil is a very expensive product for Narcolepsy. The price on this product was increased over 40% (approx) a few months ago. I am a clinical pharmacist , and manage pharmacy programs for HMOs and Self Insured Employer Groups. The time is coming when payors will not be able to afford medications with out a large increase in Employees out of pocket expenses.

Bruce GoldbergPharmacistKOHLL'S PHARMACY & HOMECARE, INC

Rx Savings with Generic vs Branded Medications

March 28, 2011

Analysis of:Buying Brand-Name Drugs Over Generics Raises Medicaid Costs | www.bloomberg.com

With dollar shortfalls for Rx benefits, controlling drug costs is imperative. By utilizing a strict formulary of covered products, along with clear, real time messaging to the pharmacies,  the generic fill rate (GFR) will rise. With a higher GFR, savings is attained.

Alfred LewisPresidentDisease Management Purchasing Consortium International, Inc

Distinguishing Fact from Fiction in Care Management Outcomes Reports

March 8, 2011

Analysis of:States Take Lead in Adopting Medical Home Models | www.aafp.org

Too many bad policy decisions are made based on published, often peer-reviewed studies in which the numbers simply don't add up. The most often-cited example in patient-centered medical homes is the North Carolina Medicaid Community Care Access Program, alleged to save $300,000,000/year by now. However, the keynote at next week's Disease Management Colloquium in Philadelphia (www.dmconferences.com) will demonstrate that this number is fictional, and is easily refuted by actual data.

David ZimmermanPresident/OwnerDoctors of Pharmacy, Inc.

CVS vs. Walgreen's and the latest....

June 12, 2010

As a consultant and clinical pharmacist with over 30 years experience, I am glad someone.... and in this case... Walgreen's finally woke up to fees that are insulting low and a losing proposition. It has been well established the the "average expense to dispense a prescription" (the pharmacy's actual costs including rent, payroll, overhead, etc) is in the $10 range per prescription. Why would any pharmacy sign a contract with a fee of $1.50 per prescription?

Bruce GoldbergPharmacistKOHLL'S PHARMACY & HOMECARE, INC

Lupin's opportunity to drop the Lotrel margin!

February 15, 2010

Analysis of:Lupin gets US FDA approval for hypertension capsules | www.pharmabiz.com

The approval of Lupin's generic Lotrel line will create one more player in a field that is currently not very crowded. Yet, don't expect the other players to not react! Generic Lotrel is currently priced relatively high compared to other multi-source hypertensive products.

Bruce GoldbergPharmacistKOHLL'S PHARMACY & HOMECARE, INC

Cetirizine OTC liquid. A day late and a dollar short.

February 8, 2010

Analysis of:Aurobindo Pharma receives final approval for Cetirizine Hydrochloride Solution (OTC) | www.pipelinereview.com

Why the delay? Teva, Taro, and Perrigo all have strong footholds in this market. Rx and OTC competition remains strong, thus what would allow a new player to grow quickly outside of eroding the price market?

Jeanette PlowmanIndependent ConsultantJeanette Plowman

ADP's Midmarket HRO Business Heats Up

December 12, 2009

Analysis of:ADP Delivers Breakthrough Integrated Workforce Management Solution | www.ebizq.net

Experts agree that the two leading suppliers in midmarket HR outsourcing today are ADP, which has 43 clients with an average of 9,200 employees each, and Ceridian, with 25 clients that have an average of 4,000 employees each. But the competition is increasing. On one hand, professional employer organizations, which typically target companies with fewer than 500 employees, are moving up-market.

David ZimmermanPresident/OwnerDoctors of Pharmacy, Inc.

Tamper Proof Narcotic Pain pill? YES

November 13, 2008

Analysis of:FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com

This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.

Page : 12345678910Next1 to 10 of 125